Picture of Seagen logo

SGEN — Seagen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge Cap

Brief: Seagen Inc - Decided To Stop Further Development Of Sea-Tgt, Sgn-Alpv And Sgn-Stnv

Nov 1 (Reuters) - Seagen Inc  SGEN.O :
    * SEAGEN INC - DECIDED TO STOP FURTHER DEVELOPMENT OF
SEA-TGT,
SGN-ALPV AND SGN-STNV
    * SEAGEN INC SAYS DECIDED THAT OUR ECHELON-3 ADCETRIS TRIAL
IN
DIFFUSE LARGE B-CELL LYMPHOMA WILL NO LONGER BE CONSIDERED
REGISTRATIONAL - SEC FILING
    * SEAGEN INC - HAVE GOAL OF SUBMITTING INDS FOR FOUR NOVEL
DRUG
CANDIDATES IN 2023 BY YEAR END

Source text for Eikon:  ID: 
Further company coverage:  SGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Seagen

See all news